InvestorsHub Logo

CatfishHunter

03/17/23 4:42 PM

#158774 RE: SC8 #158773

Who said “messing with animal tests” was a catalyst? Get your facts straight. Frank Luntz has a better track record.

Vivos is on track with last feedback expected early April before green light for IDE submission.

HoneyBager

03/17/23 7:21 PM

#158780 RE: SC8 #158773

If it’s a newbie playing an fda play then they wouldn’t be scared off by any means on pet testing providing they do their due diligence on how strong of a position rdgl is in. If they are playing it as a single interest of it being an fda play they will get in and sell on approval pop. Period.